{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:51:12Z","timestamp":1790268672880,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T00:00:00Z","timestamp":1494806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T00:00:00Z","timestamp":1494806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Patients with metastatic or relapsed gallbladder cancer generally have a poor prognosis. Therefore, targeting metastasis is one arm of therapeutic strategies to treat gallbladder cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Levels of translationally controlled tumor protein (TCTP) were measured in samples of gallbladder cancer by immunohistochemical staining. Wound healing, migration and invasion assays were used to investigate the motility of cells. Western blot assay was used to investigate the levels of TCTP and other proteins. Liver metastasis models and lung metastasis models were established to investigate the inhibitory effect of Dihydroartemisinin on gallbladder cancer metastasis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>TCTP is aberrantly expressed in gallbladder cancer patients and associated with metastasis and a poor prognosis. Depleting TCTP significantly inhibited gallbladder cancer cell migration and invasion. We found that Dihydroartemisinin as a potent inhibitor of TCTP inhibited TCTP-dependent cell migration and invasion by reducing cell division control protein 42 homolog (Cdc42) activation. In addition, in mice with xenografted tumors, treatment with Dihydroartemisinin decreased gallbladder cancer cell metastases and improved survival.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These findings provide new insights into the therapeutic activity of Dihydroartemisinin as a treatment for gallbladder cancer metastasis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13046-017-0531-3","type":"journal-article","created":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T15:58:18Z","timestamp":1494863898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Dihydroartemisinin inhibits TCTP-dependent metastasis in gallbladder cancer"],"prefix":"10.1186","volume":"36","author":[{"given":"Fei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaifeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingbin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,15]]},"reference":[{"key":"531_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/caac.21254","volume":"65","author":"RL Siegel","year":"2015","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5\u201329.","journal-title":"CA Cancer J Clin"},{"key":"531_CR2","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.canlet.2014.08.036","volume":"355","author":"M Li","year":"2014","unstructured":"Li M, Lu J, Zhang F, Li H, Zhang B, Wu X, Tan Z, Zhang L, Gao G, Mu J, et al. Yes-associated protein 1 (YAP1) promotes human gallbladder tumor growth via activation of the AXL\/MAPK pathway. Cancer Lett. 2014;355:201\u20139.","journal-title":"Cancer Lett"},{"key":"531_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12943-014-0276-y","volume":"14","author":"YJ Shu","year":"2015","unstructured":"Shu YJ, Weng H, Ye YY, Hu YP, Bao RF, Cao Y, Wang XA, Zhang F, Xiang SS, Li HF, et al. SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K\/AKT pathway. Mol Cancer. 2015;14:12.","journal-title":"Mol Cancer"},{"key":"531_CR4","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/1476-4598-13-156","volume":"13","author":"MZ Ma","year":"2014","unstructured":"Ma MZ, Li CX, Zhang Y, Weng MZ, Zhang MD, Qin YY, Gong W, Quan ZW. Long non-coding RNA HOTAIR, a c-Myc activated driver of malignancy, negatively regulates miRNA-130a in gallbladder cancer. Mol Cancer. 2014;13:156.","journal-title":"Mol Cancer"},{"key":"531_CR5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1476-4598-13-82","volume":"13","author":"M Weng","year":"2014","unstructured":"Weng M, Gong W, Ma M, Chu B, Qin Y, Zhang M, Lun X, McFadden G, Forsyth P, Yang Y, Quan Z. Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo. Mol Cancer. 2014;13:82.","journal-title":"Mol Cancer"},{"key":"531_CR6","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/ng.3030","volume":"46","author":"M Li","year":"2014","unstructured":"Li M, Zhang Z, Li X, Ye J, Wu X, Tan Z, Liu C, Shen B, Wang XA, Wu W, et al. Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway. Nat Genet. 2014;46:872\u20136.","journal-title":"Nat Genet"},{"key":"531_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13046-016-0346-7","volume":"35","author":"Y Cao","year":"2016","unstructured":"Cao Y, Liang H, Zhang F, Luan Z, Zhao S, Wang XA, Liu S, Bao R, Shu Y, Ma Q, et al. Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer. J Exp Clin Cancer Res. 2016;35:68.","journal-title":"J Exp Clin Cancer Res"},{"key":"531_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.canlet.2016.02.049","volume":"375","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Liu S, Wang L, Wu Y, Hao J, Wang Z, Lu W, Wang XA, Zhang F, Cao Y, et al. A novel PI3K\/AKT signaling axis mediates Nectin-4-induced gallbladder cancer cell proliferation, metastasis and tumor growth. Cancer Lett. 2016;375:179\u201389.","journal-title":"Cancer Lett"},{"key":"531_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2011.12.021","volume":"148","author":"DA Tuveson","year":"2012","unstructured":"Tuveson DA, Neoptolemos JP. Understanding metastasis in pancreatic cancer: a call for new clinical approaches. Cell. 2012;148:21\u20133.","journal-title":"Cell"},{"key":"531_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.tcb.2012.10.002","volume":"23","author":"R Amson","year":"2013","unstructured":"Amson R, Pece S, Marine JC, Di Fiore PP, Telerman A. TPT1\/TCTP-regulated pathways in phenotypic reprogramming. Trends Cell Biol. 2013;23:37\u201346.","journal-title":"Trends Cell Biol"},{"key":"531_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nm.2546","volume":"18","author":"R Amson","year":"2011","unstructured":"Amson R, Pece S, Lespagnol A, Vyas R, Mazzarol G, Tosoni D, Colaluca I, Viale G, Rodrigues-Ferreira S, Wynendaele J, et al. Reciprocal repression between P53 and TCTP. Nat Med. 2011;18:91\u20139.","journal-title":"Nat Med"},{"key":"531_CR12","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/nature05528","volume":"445","author":"YC Hsu","year":"2007","unstructured":"Hsu YC, Chern JJ, Cai Y, Liu M, Choi KW. Drosophila TCTP is essential for growth and proliferation through regulation of dRheb GTPase. Nature. 2007;445:785\u20138.","journal-title":"Nature"},{"key":"531_CR13","doi-asserted-by":"publisher","first-page":"14976","DOI":"10.1073\/pnas.222470799","volume":"99","author":"M Tuynder","year":"2002","unstructured":"Tuynder M, Susini L, Prieur S, Besse S, Fiucci G, Amson R, Telerman A. Biological models and genes of tumor reversion: cellular reprogramming through tpt1\/TCTP and SIAH-1. Proc Natl Acad Sci U S A. 2002;99:14976\u201381.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"531_CR14","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/hep.24709","volume":"55","author":"THM Chan","year":"2012","unstructured":"Chan THM, Chen L, Liu M, Hu L, Zheng B-j, Poon VK-M, Huang P, Yuan Y-F, Huang J-d, Yang J, et al. Translationally controlled tumor protein induces mitotic defects and chromosome missegregation in hepatocellular carcinoma development. Hepatology. 2012;55:491\u2013505.","journal-title":"Hepatology"},{"key":"531_CR15","doi-asserted-by":"publisher","first-page":"8061","DOI":"10.1038\/srep08061","volume":"5","author":"SY Bae","year":"2015","unstructured":"Bae SY, Kim HJ, Lee KJ, Lee K. Translationally controlled tumor protein induces epithelial to mesenchymal transition and promotes cell migration, invasion and metastasis. Sci Rep. 2015;5:8061.","journal-title":"Sci Rep"},{"key":"531_CR16","doi-asserted-by":"crossref","first-page":"50057","DOI":"10.18632\/oncotarget.10315","volume":"7","author":"B Xiao","year":"2016","unstructured":"Xiao B, Chen D, Luo S, Hao W, Jing F, Liu T, Wang S, Geng Y, Li L, Xu W, et al. Extracellular translationally controlled tumor protein promotes colorectal cancer invasion and metastasis through Cdc42\/JNK\/MMP9 signaling. Oncotarget. 2016;7:50057\u201373.","journal-title":"Oncotarget"},{"key":"531_CR17","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1158\/1541-7786.MCR-13-0389","volume":"11","author":"F Zhang","year":"2013","unstructured":"Zhang F, Liu B, Wang Z, Yu XJ, Ni QX, Yang WT, Mukaida N, Li YY. A novel regulatory mechanism of Pim-3 kinase stability and its involvement in pancreatic cancer progression. Mol Cancer Res. 2013;11:1508\u201320.","journal-title":"Mol Cancer Res"},{"key":"531_CR18","doi-asserted-by":"publisher","first-page":"247597","DOI":"10.1155\/2012\/247597","volume":"2012","author":"MP Crespo-Ortiz","year":"2012","unstructured":"Crespo-Ortiz MP, Wei MQ. Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug. J Biomed Biotechnol. 2012;2012:247597.","journal-title":"J Biomed Biotechnol"},{"key":"531_CR19","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.pharmthera.2013.12.001","volume":"142","author":"WE Ho","year":"2014","unstructured":"Ho WE, Peh HY, Chan TK, Wong WS. Artemisinins: pharmacological actions beyond anti-malarial. Pharmacol Ther. 2014;142:126\u201339.","journal-title":"Pharmacol Ther"},{"key":"531_CR20","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.febslet.2008.02.055","volume":"582","author":"T Fujita","year":"2008","unstructured":"Fujita T, Felix K, Pinkaew D, Hutadilok-Towatana N, Liu Z, Fujise K. Human fortilin is a molecular target of dihydroartemisinin. FEBS Lett. 2008;582:1055\u201360.","journal-title":"FEBS Lett"},{"key":"531_CR21","doi-asserted-by":"publisher","first-page":"5275","DOI":"10.18632\/oncotarget.2971","volume":"6","author":"M Lucibello","year":"2015","unstructured":"Lucibello M, Adanti S, Antelmi E, Dezi D, Ciafre S, Carcangiu ML, Zonfrillo M, Nicotera G, Sica L, De Braud F, Pierimarchi P. Phospho-TCTP as a therapeutic target of Dihydroartemisinin for aggressive breast cancer cells. Oncotarget. 2015;6:5275\u201391.","journal-title":"Oncotarget"},{"key":"531_CR22","first-page":"3969","volume":"9","author":"F Zhang","year":"2015","unstructured":"Zhang F, Li M, Wu X, Hu Y, Cao Y, Wang X, Xiang S, Li H, Jiang L, Tan Z, et al. 20(S)-ginsenoside Rg3 promotes senescence and apoptosis in gallbladder cancer cells via the p53 pathway. Drug Des Devel Ther. 2015;9:3969\u201387.","journal-title":"Drug Des Devel Ther"},{"key":"531_CR23","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.ctrv.2014.02.007","volume":"40","author":"J Acunzo","year":"2014","unstructured":"Acunzo J, Baylot V, So A, Rocchi P. TCTP as therapeutic target in cancers. Cancer Treat Rev. 2014;40:760\u20139.","journal-title":"Cancer Treat Rev"},{"key":"531_CR24","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1158\/1535-7163.MCT-10-0051","volume":"9","author":"R Handrick","year":"2010","unstructured":"Handrick R, Ontikatze T, Bauer KD, Freier F, Rubel A, Durig J, Belka C, Jendrossek V. Dihydroartemisinin induces apoptosis by a Bak-dependent intrinsic pathway. Mol Cancer Ther. 2010;9:2497\u2013510.","journal-title":"Mol Cancer Ther"},{"key":"531_CR25","doi-asserted-by":"crossref","first-page":"62460","DOI":"10.18632\/oncotarget.11517","volume":"7","author":"Y Li","year":"2016","unstructured":"Li Y, Wang Y, Kong R, Xue D, Pan S, Chen H, Sun B. Dihydroartemisinin suppresses pancreatic cancer cells via a microRNA-mRNA regulatory network. Oncotarget. 2016;7:62460\u201373.","journal-title":"Oncotarget."},{"key":"531_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.canlet.2010.01.001","volume":"293","author":"SJ Wang","year":"2010","unstructured":"Wang SJ, Gao Y, Chen H, Kong R, Jiang HC, Pan SH, Xue DB, Bai XW, Sun B. Dihydroartemisinin inactivates NF-kappaB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo. Cancer Lett. 2010;293:99\u2013108.","journal-title":"Cancer Lett"},{"key":"531_CR27","first-page":"773","volume":"28","author":"C Tang","year":"2015","unstructured":"Tang C, Zhao Y, Huang S, Jin Y, Liu J, Luo J, Zheng J, Shi D. Influence of Artemisia annua extract derivatives on proliferation, apoptosis and metastasis of osteosarcoma cells. Pak J Pharm Sci. 2015;28:773\u20139.","journal-title":"Pak J Pharm Sci"},{"key":"531_CR28","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s00228-014-1754-2","volume":"70","author":"T Ericsson","year":"2014","unstructured":"Ericsson T, Blank A, von Hagens C, Ashton M, Abelo A. Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer. Eur J Clin Pharmacol. 2014;70:1453\u201363.","journal-title":"Eur J Clin Pharmacol"},{"key":"531_CR29","doi-asserted-by":"crossref","first-page":"87271","DOI":"10.18632\/oncotarget.13536","volume":"7","author":"J Jiang","year":"2016","unstructured":"Jiang J, Geng G, Yu X, Liu H, Gao J, An H, Cai C, Li N, Shen D, Wu X, et al. Repurposing the anti-malarial drug dihydroartemisinin suppresses metastasis of non-small-cell lung cancer via inhibiting NF-kappaB\/GLUT1 axis. Oncotarget. 2016;7:87271\u201383.","journal-title":"Oncotarget."},{"key":"531_CR30","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/cbdd.12556","volume":"86","author":"MI Qadir","year":"2015","unstructured":"Qadir MI, Parveen A, Ali M. Cdc42: role in cancer management. Chem Biol Drug Des. 2015;86:432\u20139.","journal-title":"Chem Biol Drug Des"},{"key":"531_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13046-017-0503-7","volume":"36","author":"DF Meng","year":"2017","unstructured":"Meng DF, Xie P, Peng LX, Sun R, Luo DH, Chen QY, Lv X, Wang L, Chen MY, Mai HQ, et al. Erratum to: CDC42-interacting protein 4 promotes metastasis of nasopharyngeal carcinoma by mediating invadopodia formation and activating EGFR signaling. J Exp Clin Cancer Res. 2017;36:33.","journal-title":"J Exp Clin Cancer Res"},{"key":"531_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13046-016-0483-z","volume":"36","author":"DF Meng","year":"2017","unstructured":"Meng DF, Xie P, Peng LX, Sun R, Luo DH, Chen QY, Lv X, Wang L, Chen MY, Mai HQ, et al. CDC42-interacting protein 4 promotes metastasis of nasopharyngeal carcinoma by mediating invadopodia formation and activating EGFR signaling. J Exp Clin Cancer Res. 2017;36:21.","journal-title":"J Exp Clin Cancer Res"},{"key":"531_CR33","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1158\/1535-7163.MCT-15-0419","volume":"14","author":"Y Guo","year":"2015","unstructured":"Guo Y, Kenney SR, Muller CY, Adams S, Rutledge T, Romero E, Murray-Krezan C, Prekeris R, Sklar LA, Hudson LG, Wandinger-Ness A. R-ketorolac targets Cdc42 and Rac1 and alters ovarian cancer cell behaviors critical for invasion and metastasis. Mol Cancer Ther. 2015;14:2215\u201327.","journal-title":"Mol Cancer Ther"},{"key":"531_CR34","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1093\/carcin\/bgp022","volume":"30","author":"F Bazile","year":"2009","unstructured":"Bazile F, Pascal A, Arnal I, Le Clainche C, Chesnel F, Kubiak JZ. Complex relationship between TCTP, microtubules and actin microfilaments regulates cell shape in normal and cancer cells. Carcinogenesis. 2009;30:555\u201365.","journal-title":"Carcinogenesis"},{"key":"531_CR35","first-page":"123","volume":"33","author":"Y Gong","year":"2013","unstructured":"Gong Y, Gallis BM, Goodlett DR, Yang Y, Lu H, Lacoste E, Lai H, Sasaki T. Effects of transferrin conjugates of artemisinin and artemisinin dimer on breast cancer cell lines. Anticancer Res. 2013;33:123\u201332.","journal-title":"Anticancer Res"},{"key":"531_CR36","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2174\/138945006776359412","volume":"7","author":"T Efferth","year":"2006","unstructured":"Efferth T. Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells. Curr Drug Targets. 2006;7:407\u201321.","journal-title":"Curr Drug Targets"},{"key":"531_CR37","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.bbrc.2014.01.053","volume":"444","author":"X Feng","year":"2014","unstructured":"Feng X, Li L, Jiang H, Jiang K, Jin Y, Zheng J. Dihydroartemisinin potentiates the anticancer effect of cisplatin via mTOR inhibition in cisplatin-resistant ovarian cancer cells: involvement of apoptosis and autophagy. Biochem Biophys Res Commun. 2014;444:376\u201381.","journal-title":"Biochem Biophys Res Commun"},{"key":"531_CR38","first-page":"575","volume":"35","author":"K Na-Bangchang","year":"2004","unstructured":"Na-Bangchang K, Krudsood S, Silachamroon U, Molunto P, Tasanor O, Chalermrut K, Tangpukdee N, Matangkasombut O, Kano S, Looareesuwan S. The pharmacokinetics of oral dihydroartemisinin and artesunate in healthy Thai volunteers. Southeast Asian J Trop Med Public Health. 2004;35:575\u201382.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"531_CR39","doi-asserted-by":"publisher","first-page":"6976","DOI":"10.1158\/0008-5472.CAN-11-0627","volume":"71","author":"LG Daenen","year":"2011","unstructured":"Daenen LG, Roodhart JM, van Amersfoort M, Dehnad M, Roessingh W, Ulfman LH, Derksen PW, Voest EE. Chemotherapy enhances metastasis formation via VEGFR-1-expressing endothelial cells. Cancer Res. 2011;71:6976\u201385.","journal-title":"Cancer Res"},{"key":"531_CR40","doi-asserted-by":"publisher","first-page":"6986","DOI":"10.1158\/0008-5472.CAN-11-0629","volume":"71","author":"S Gingis-Velitski","year":"2011","unstructured":"Gingis-Velitski S, Loven D, Benayoun L, Munster M, Bril R, Voloshin T, Alishekevitz D, Bertolini F, Shaked Y. Host response to short-term, single-agent chemotherapy induces matrix metalloproteinase-9 expression and accelerates metastasis in mice. Cancer Res. 2011;71:6986\u201396.","journal-title":"Cancer Res"}],"updated-by":[{"DOI":"10.1186\/s13046-022-02325-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T00:00:00Z","timestamp":1649030400000}},{"DOI":"10.1186\/s13046-019-1378-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000}}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-017-0531-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-017-0531-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-017-0531-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T02:02:43Z","timestamp":1649037763000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-017-0531-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,15]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["531"],"URL":"https:\/\/doi.org\/10.1186\/s13046-017-0531-3","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,15]]},"assertion":[{"value":"3 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original publication of this article [1], there are mistakes in Fig.\u00a03A and Fig.\u00a03D.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2022","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13046-022-02325-1","URL":"https:\/\/doi.org\/10.1186\/s13046-022-02325-1","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"68"}}